BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tempera I, Lieberman PM. Epigenetic regulation of EBV persistence and oncogenesis. Semin Cancer Biol 2014;26:22-9. [PMID: 24468737 DOI: 10.1016/j.semcancer.2014.01.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Dugan JP, Coleman CB, Haverkos B. Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders. Front Oncol 2019;9:127. [PMID: 30931253 DOI: 10.3389/fonc.2019.00127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
2 De Leo A, Calderon A, Lieberman PM. Control of Viral Latency by Episome Maintenance Proteins. Trends Microbiol 2020;28:150-62. [PMID: 31624007 DOI: 10.1016/j.tim.2019.09.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
3 Lam WKJ, Jiang P, Chan KCA, Peng W, Shang H, Heung MMS, Cheng SH, Zhang H, Tse OYO, Raghupathy R, Ma BBY, Hui EP, Chan ATC, Woo JKS, Chiu RWK, Lo YMD. Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases. Nat Commun 2019;10:3256. [PMID: 31332191 DOI: 10.1038/s41467-019-11226-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
4 Hegde M, Joshi MB. Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors. J Cancer Res Clin Oncol 2021;147:937-71. [PMID: 33604794 DOI: 10.1007/s00432-021-03519-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Tsang CM, Tsao SW. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Virol Sin 2015;30:107-21. [PMID: 25910483 DOI: 10.1007/s12250-015-3592-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 8.1] [Reference Citation Analysis]
6 Sadato D, Ogawa M, Hirama C, Hishima T, Horiguchi SI, Harada Y, Shimoyama T, Itokawa M, Ohashi K, Oboki K. Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort. FEBS Open Bio 2020;10:455-67. [PMID: 31991047 DOI: 10.1002/2211-5463.12803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Malecka KA, Dheekollu J, Deakyne JS, Wiedmer A, Ramirez UD, Lieberman PM, Messick TE. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication. J Virol 2019;93:e00487-19. [PMID: 31142669 DOI: 10.1128/JVI.00487-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Sun YW, Tee CS, Ma YH, Wang G, Yao XM, Ye J. Attenuation of Histone Methyltransferase KRYPTONITE-mediated transcriptional gene silencing by Geminivirus. Sci Rep 2015;5:16476. [PMID: 26602265 DOI: 10.1038/srep16476] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
9 Liu F, Zhou Y, Zhou D, Kan M, Niu X, Zhang Z, Zhang D, Tao L, He L, Zhan L. Whole DNA methylome profiling in lung cancer cells before and after epithelial-to-mesenchymal transition. Diagn Pathol. 2014;9:66. [PMID: 24655585 DOI: 10.1186/1746-1596-9-66] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
10 Stanland LJ, Luftig MA. The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis. Viruses 2020;12:E1222. [PMID: 33126718 DOI: 10.3390/v12111222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Birdwell CE, Queen KJ, Kilgore PC, Rollyson P, Trutschl M, Cvek U, Scott RS. Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes. J Virol 2014;88:11442-58. [PMID: 25056883 DOI: 10.1128/JVI.00972-14] [Cited by in Crossref: 68] [Cited by in F6Publishing: 46] [Article Influence: 8.5] [Reference Citation Analysis]
12 Lang F, Li X, Vladimirova O, Hu B, Chen G, Xiao Y, Singh V, Lu D, Li L, Han H, Wickramasinghe JM, Smith ST, Zheng C, Li Q, Lieberman PM, Fraser NW, Zhou J. CTCF interacts with the lytic HSV-1 genome to promote viral transcription. Sci Rep 2017;7:39861. [PMID: 28045091 DOI: 10.1038/srep39861] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
13 Vargas-Ayala RC, Jay A, Manara F, Maroui MA, Hernandez-Vargas H, Diederichs A, Robitaille A, Sirand C, Ceraolo MG, Romero-Medina MC, Cros MP, Cuenin C, Durand G, Le Calvez-Kelm F, Mundo L, Leoncini L, Manet E, Herceg Z, Gruffat H, Accardi R. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection. J Virol 2019;93:e00273-19. [PMID: 30996097 DOI: 10.1128/JVI.00273-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Ose N, Kawagishi S, Funaki S, Kanou T, Fukui E, Kimura K, Minami M, Shintani Y. Thymic Lymphoepithelial Carcinoma Associated with Epstein-Barr Virus: Experiences and Literature Review. Cancers (Basel) 2021;13:4794. [PMID: 34638279 DOI: 10.3390/cancers13194794] [Reference Citation Analysis]
15 Meier UC, Cipian RC, Karimi A, Ramasamy R, Middeldorp JM. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis. Front Immunol 2021;12:757302. [PMID: 34790199 DOI: 10.3389/fimmu.2021.757302] [Reference Citation Analysis]
16 Vega F, Amador C, Chadburn A, Hsi ED, Slack G, Medeiros LJ, Feldman AL. Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up. Mod Pathol 2021. [PMID: 34584212 DOI: 10.1038/s41379-021-00937-0] [Reference Citation Analysis]
17 Miyazato P, Matsuo M, Katsuya H, Satou Y. Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus. Viruses 2016;8:E171. [PMID: 27322309 DOI: 10.3390/v8060171] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
18 Majumder K, Morales AJ. Utilization of Host Cell Chromosome Conformation by Viral Pathogens: Knowing When to Hold and When to Fold. Front Immunol 2021;12:633762. [PMID: 33841414 DOI: 10.3389/fimmu.2021.633762] [Reference Citation Analysis]
19 Pierangeli A, Antonelli G, Gentile G. Immunodeficiency-associated viral oncogenesis. Clin Microbiol Infect 2015;21:975-83. [PMID: 26197213 DOI: 10.1016/j.cmi.2015.07.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
20 Tse E, Kwong YL. Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target. Exp Mol Med 2015;47:e136. [PMID: 25613733 DOI: 10.1038/emm.2014.102] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
21 Ichikawa T, Okuno Y, Sato Y, Goshima F, Yoshiyama H, Kanda T, Kimura H, Murata T. Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells. mSphere 2018;3:e00478-18. [PMID: 30487153 DOI: 10.1128/mSphere.00478-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
22 Satou Y, Miyazato P, Ishihara K, Yaguchi H, Melamed A, Miura M, Fukuda A, Nosaka K, Watanabe T, Rowan AG, Nakao M, Bangham CR. The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome. Proc Natl Acad Sci U S A 2016;113:3054-9. [PMID: 26929370 DOI: 10.1073/pnas.1423199113] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 11.7] [Reference Citation Analysis]
23 Wang J, Liu W, Zhang X, Zhang Y, Xiao H, Luo B. LMP2A induces DNA methylation and expression repression of AQP3 in EBV-associated gastric carcinoma. Virology 2019;534:87-95. [PMID: 31220652 DOI: 10.1016/j.virol.2019.06.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
24 Balakrishnan L, Milavetz B. Epigenetic Regulation of Viral Biological Processes. Viruses 2017;9:E346. [PMID: 29149060 DOI: 10.3390/v9110346] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
25 Gru AA, Haverkos BH, Freud AG, Hastings J, Nowacki NB, Barrionuevo C, Vigil CE, Rochford R, Natkunam Y, Baiocchi RA, Porcu P. The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment. Curr Hematol Malig Rep 2015;10:456-67. [PMID: 26449716 DOI: 10.1007/s11899-015-0292-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
26 Sharifpour C, Makvandi M, Samarbafzadeh A, Talaei-Zadeh A, Ranjbari N, Nisi N, Azaran A, Jalilian S, Varnaseri M, Pirmoradi R, Ahmadi Angali K. Frequency of Epstein–Barr Virus DNA in Formalin-Fixed Paraffin-Embedded Tissue of Patients with Ductal Breast Carcinoma. Asian Pac J Cancer Prev 2019;20:687-92. [PMID: 30909665 DOI: 10.31557/APJCP.2019.20.3.687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
27 El-Araby AM, Fouad AA, Hanbal AM, Abdelwahab SM, Qassem OM, El-Araby ME. Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises. Arch Pharm (Weinheim) 2016;349:73-90. [PMID: 26754591 DOI: 10.1002/ardp.201500375] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
28 Kim KD, Tanizawa H, De Leo A, Vladimirova O, Kossenkov A, Lu F, Showe LC, Noma KI, Lieberman PM. Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus. Nat Commun 2020;11:877. [PMID: 32054837 DOI: 10.1038/s41467-019-14152-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
29 Rouka E, Kyriakou D. Identification and functional analysis of the BIM interactome; new clues on its possible involvement in Epstein-Barr Virus-associated diseases. J Biol Res (Thessalon) 2015;22:14. [PMID: 26702402 DOI: 10.1186/s40709-015-0037-0] [Reference Citation Analysis]
30 Sarwari NM, Khoury JD, Hernandez CM. Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma. BMC Hematol 2016;16:19. [PMID: 27437106 DOI: 10.1186/s12878-016-0059-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
31 Price AM, Messinger JE, Luftig MA. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection. J Virol 2018;92:e01178-17. [PMID: 29118124 DOI: 10.1128/JVI.01178-17] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
32 Henderson HH, Timberlake KB, Austin ZA, Badani H, Sanford B, Tremblay K, Baird NL, Jones K, Rovnak J, Frietze S, Gilden D, Cohrs RJ. Occupancy of RNA Polymerase II Phosphorylated on Serine 5 (RNAP S5P) and RNAP S2P on Varicella-Zoster Virus Genes 9, 51, and 66 Is Independent of Transcript Abundance and Polymerase Location within the Gene. J Virol 2016;90:1231-43. [PMID: 26559844 DOI: 10.1128/JVI.02617-15] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
33 Mota TM, Jones RB. HTLV-1 as a Model for Virus and Host Coordinated Immunoediting. Front Immunol 2019;10:2259. [PMID: 31616431 DOI: 10.3389/fimmu.2019.02259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Liu W, Luo B. The impact of EBV on the epigenetics of gastric carcinoma. Future Virology 2020;15:183-93. [DOI: 10.2217/fvl-2019-0148] [Reference Citation Analysis]
35 Lieberman PM. Chromatin Structure of Epstein-Barr Virus Latent Episomes. Curr Top Microbiol Immunol 2015;390:71-102. [PMID: 26424644 DOI: 10.1007/978-3-319-22822-8_5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
36 Tsai K, Cullen BR. Epigenetic and epitranscriptomic regulation of viral replication. Nat Rev Microbiol 2020;18:559-70. [PMID: 32533130 DOI: 10.1038/s41579-020-0382-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
37 Wen Y, Xu H, Han J, Jin R, Chen H. How Does Epstein–Barr Virus Interact With Other Microbiomes in EBV-Driven Cancers? Front Cell Infect Microbiol 2022;12:852066. [DOI: 10.3389/fcimb.2022.852066] [Reference Citation Analysis]
38 Bryer E, Henry D. Isolated hypoglossal nerve palsy as a presenting symptom of metastatic peripheral T-cell lymphoma - not otherwise specified (PTCL-NOS): a unique case & a review of the literature. Int J Hematol Oncol 2018;7:IJH03. [PMID: 30302235 DOI: 10.2217/ijh-2018-0002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Gomes AV, de Souza Morais SM, Menezes-Filho SL, de Almeida LG, Rocha RP, Ferreira JM, Dos Santos LL, Malaquias LC, Coelho LF. Demethylation profile of the TNF-α promoter gene is associated with high expression of this cytokine in Dengue virus patients. J Med Virol 2016;88:1297-302. [PMID: 26792115 DOI: 10.1002/jmv.24478] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
40 Scott RS. Epstein-Barr virus: a master epigenetic manipulator. Curr Opin Virol 2017;26:74-80. [PMID: 28780440 DOI: 10.1016/j.coviro.2017.07.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
41 Lieberman PM. Epigenetics and Genetics of Viral Latency. Cell Host Microbe 2016;19:619-28. [PMID: 27173930 DOI: 10.1016/j.chom.2016.04.008] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 15.2] [Reference Citation Analysis]
42 Tsang CM, Deng W, Yip YL, Zeng MS, Lo KW, Tsao SW. Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells. Chin J Cancer 2014;33:549-55. [PMID: 25223910 DOI: 10.5732/cjc.014.10169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 22] [Article Influence: 0.4] [Reference Citation Analysis]
43 Murata T, Sugimoto A, Inagaki T, Yanagi Y, Watanabe T, Sato Y, Kimura H. Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation. Viruses 2021;13:2344. [PMID: 34960613 DOI: 10.3390/v13122344] [Reference Citation Analysis]
44 Ko YH. EBV and human cancer. Exp Mol Med 2015;47:e130. [PMID: 25613727 DOI: 10.1038/emm.2014.109] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
45 Lupey-Green LN, Caruso LB, Madzo J, Martin KA, Tan Y, Hulse M, Tempera I. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type. J Virol 2018;92:e00755-18. [PMID: 29976663 DOI: 10.1128/JVI.00755-18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
46 Adler B, Sattler C, Adler H. Herpesviruses and Their Host Cells: A Successful Liaison. Trends in Microbiology 2017;25:229-41. [DOI: 10.1016/j.tim.2016.11.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
47 Zhang J, Huang T, Zhou Y, Cheng ASL, Yu J, To KF, Kang W. The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Cell Mol Med 2018;22:38-45. [PMID: 28990284 DOI: 10.1111/jcmm.13354] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
48 Lin RK, Wang YC. Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer. Cell Biosci 2014;4:46. [PMID: 25949795 DOI: 10.1186/2045-3701-4-46] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
49 Ratner L. Epigenetic Regulation of Human T-Cell Leukemia Virus Gene Expression. Microorganisms 2021;10:84. [PMID: 35056532 DOI: 10.3390/microorganisms10010084] [Reference Citation Analysis]
50 Allday MJ, Bazot Q, White RE. The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells. Curr Top Microbiol Immunol 2015;391:61-117. [PMID: 26428372 DOI: 10.1007/978-3-319-22834-1_3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
51 Wang S, Mo Y, Midorikawa K, Zhang Z, Huang G, Ma N, Zhao W, Hiraku Y, Oikawa S, Murata M. The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L. Oncotarget 2015;6:35893-907. [PMID: 26486082 DOI: 10.18632/oncotarget.5651] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
52 Lu F, Wiedmer A, Martin KA, Wickramasinghe PJMS, Kossenkov AV, Lieberman PM. Coordinate Regulation of TET2 and EBNA2 Controls the DNA Methylation State of Latent Epstein-Barr Virus. J Virol 2017;91:e00804-17. [PMID: 28794029 DOI: 10.1128/JVI.00804-17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
53 Garolla A, Vitagliano A, Muscianisi F, Valente U, Ghezzi M, Andrisani A, Ambrosini G, Foresta C. Role of Viral Infections in Testicular Cancer Etiology: Evidence From a Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2019;10:355. [PMID: 31263452 DOI: 10.3389/fendo.2019.00355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
54 Wille CK, Nawandar DM, Henning AN, Ma S, Oetting KM, Lee D, Lambert P, Johannsen EC, Kenney SC. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch. Proc Natl Acad Sci U S A 2015;112:E7257-65. [PMID: 26663912 DOI: 10.1073/pnas.1513432112] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
55 Dochnal SA, Francois AK, Cliffe AR. De Novo Polycomb Recruitment: Lessons from Latent Herpesviruses. Viruses 2021;13:1470. [PMID: 34452335 DOI: 10.3390/v13081470] [Reference Citation Analysis]
56 Yoon SE, Kim SJ, Yoon DH, Koh Y, Mun YC, Do YR, Choi YS, Yang DH, Kim MK, Lee GW, Suh C, Ko YH, Kim WS. A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis. Ann Hematol 2020;99:1283-91. [PMID: 32333154 DOI: 10.1007/s00277-020-04005-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Elder EG, Krishna BA, Poole E, Perera M, Sinclair J. Regulation of host and viral promoters during human cytomegalovirus latency via US28 and CTCF. J Gen Virol 2021;102. [PMID: 34042564 DOI: 10.1099/jgv.0.001609] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Watson MM, Søreide K. The Gut Microbiota Influence on Human Epigenetics, Health, and Disease. Handbook of Epigenetics. Elsevier; 2017. pp. 495-510. [DOI: 10.1016/b978-0-12-805388-1.00032-8] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
59 Mabuchi S, Hijioka F, Watanabe T, Yanagi Y, Okuno Y, Masud HMAA, Sato Y, Murata T, Kimura H. Role of Epstein-Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma. Cancers (Basel) 2021;13:561. [PMID: 33535665 DOI: 10.3390/cancers13030561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
60 Fernandes Q, Merhi M, Raza A, Inchakalody VP, Abdelouahab N, Zar Gul AR, Uddin S, Dermime S. Role of Epstein-Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target. Front Oncol 2018;8:257. [PMID: 30035101 DOI: 10.3389/fonc.2018.00257] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
61 Lee S, Park HY, Kang SY, Kim SJ, Hwang J, Lee S, Kwak SH, Park KS, Yoo HY, Kim WS, Kim JI, Ko YH. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type. Oncotarget 2015;6:17764-76. [PMID: 25980440 DOI: 10.18632/oncotarget.3776] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 13.7] [Reference Citation Analysis]
62 Atyeo N, Rodriguez MD, Papp B, Toth Z. Clinical Manifestations and Epigenetic Regulation of Oral Herpesvirus Infections. Viruses 2021;13:681. [PMID: 33920978 DOI: 10.3390/v13040681] [Reference Citation Analysis]
63 Lu F, Chen HS, Kossenkov AV, DeWispeleare K, Won KJ, Lieberman PM. EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1. PLoS Pathog 2016;12:e1005339. [PMID: 26752713 DOI: 10.1371/journal.ppat.1005339] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
64 Murata T, Okuno Y, Sato Y, Watanabe T, Kimura H. Oncogenesis of CAEBV revealed: Intragenic deletions in the viral genome and leaky expression of lytic genes. Rev Med Virol 2020;30:e2095. [PMID: 31845495 DOI: 10.1002/rmv.2095] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]